Skip to main content

Lexington startup raises $55M to advance Pfizer's shelved work

NodThera hopes to create treatments for chronic conditions like NASH, inflammatory bowel disease and even neurodegenerative diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.